| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/24/2004 | WO2004053138A1 Dec-205 (ly 75) / dcl-1 intergenic splice variants associated with hodkin’s disease, and uses thereof |
| 06/24/2004 | WO2004053137A2 Method for protein production |
| 06/24/2004 | WO2004053130A1 Regulatory zinc finger proteins |
| 06/24/2004 | WO2004053129A1 Methods and means for modulating cellulose biosynthesis in fiber producing plants |
| 06/24/2004 | WO2004053128A1 Mutations in gaba-b receptor 1 associated with epilepsy |
| 06/24/2004 | WO2004053121A1 PROTEIN FORMING COMPLEX WITH c-Fos PROTEIN, NUCLEIC ACID ENCODING THE SAME AND METHOD OF USING THE SAME |
| 06/24/2004 | WO2004053120A2 Regulatory elements in the 5' region of the vr1 gene |
| 06/24/2004 | WO2004053119A1 Fluorescent proteins from aquatic species |
| 06/24/2004 | WO2004053100A2 Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same |
| 06/24/2004 | WO2004053098A2 Base, a new cancer gene, and uses thereof |
| 06/24/2004 | WO2004053094A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 06/24/2004 | WO2004053092A2 Human pellino polypeptides |
| 06/24/2004 | WO2004053091A2 STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES |
| 06/24/2004 | WO2004053086A2 Plasmodium falciparum antigens and methods of use |
| 06/24/2004 | WO2004053081A2 Compositions, splice variants and methods relating to prostate specific genes and proteins |
| 06/24/2004 | WO2004053079A2 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 06/24/2004 | WO2004053077A2 Compositions,splice variants and methods relating to breast specific genes and proteins |
| 06/24/2004 | WO2004053075A2 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 06/24/2004 | WO2004053068A2 Protein modification and maintenance molecules |
| 06/24/2004 | WO2004053066A2 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 06/24/2004 | WO2004053061A2 Methods of therapy and diagnosis using targeting of cells that express lax |
| 06/24/2004 | WO2004053059A2 Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same |
| 06/24/2004 | WO2004053058A2 Junctional adhesion molecule splice variants |
| 06/24/2004 | WO2004053057A2 Gene expression systems and recombinant cell lines |
| 06/24/2004 | WO2004052933A2 Peptide oligomers for use as hiv vaccines |
| 06/24/2004 | WO2004052932A2 Antibody (“11c7”) anti nogo a and its pharmaceutical use |
| 06/24/2004 | WO2004052931A1 Negatively charged antiviral protein conjugates |
| 06/24/2004 | WO2004052930A2 Targeting single epitopes |
| 06/24/2004 | WO2004052929A2 Recombinant cell line |
| 06/24/2004 | WO2004052928A2 Midkine-like protein |
| 06/24/2004 | WO2004052927A1 A baldness related gene and the polypeptide encoded thereby, and uses thereof |
| 06/24/2004 | WO2004052926A1 Isolated fluorescent protein from clytia gregaria cgfp and use thereof |
| 06/24/2004 | WO2004052925A2 Actinobacillus pleuropneumoniae virulence genes |
| 06/24/2004 | WO2004052924A1 Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections |
| 06/24/2004 | WO2004052922A2 Peptides, antibodies thereto, and their use in the treatment of central nervous system damage |
| 06/24/2004 | WO2004052917A2 Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions |
| 06/24/2004 | WO2004052914A2 Compositions and methods for inhibiting malaria protease falcipain-2 |
| 06/24/2004 | WO2004052910A1 A full-length polynucleotide coding chicken type ii collagen and the use of it |
| 06/24/2004 | WO2004052773A2 Peptide nanostructures, methods for their preparation and use |
| 06/24/2004 | WO2004052404A2 Glycogen synthase kinase-3 inhibitors |
| 06/24/2004 | WO2004052392A2 Cancer immunotherapy using polycomb proteins |
| 06/24/2004 | WO2004052293A2 Recombinant vaccine against flavivirus infection |
| 06/24/2004 | WO2004052290A2 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 06/24/2004 | WO2004052281A2 Oral lactoferrin in the treatment of sepsis |
| 06/24/2004 | WO2004052278A2 Escape mutants of newcastle disease virus as marker vaccines |
| 06/24/2004 | WO2004052276A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/24/2004 | WO2004052273A2 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 06/24/2004 | WO2004052233A2 Canine rankl and methods for preparing and using the same |
| 06/24/2004 | WO2004052186A2 Expressed genes that define the osteoclast phenotype |
| 06/24/2004 | WO2004052094A1 Method to treat conditions associated with insulin signaling dysregulation |
| 06/24/2004 | WO2004052092A1 Sigma receptor-deficient, mutant, non-human mammals and applications thereof |
| 06/24/2004 | WO2004041852A3 Hiv vaccine |
| 06/24/2004 | WO2004039839A3 Modified voltage-gated calcium channels |
| 06/24/2004 | WO2004035625A3 Method of obtaining biologically active collagen from skins of the salmonidae fish |
| 06/24/2004 | WO2004033627A3 Methods for efficient production of mammalian recombinant proteins |
| 06/24/2004 | WO2004031236A3 Therapeutic uspa1-derived peptides |
| 06/24/2004 | WO2004024925A3 Collectin-complement activating protein chimeras |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2004022594A3 Immune modulatory compounds and methods |
| 06/24/2004 | WO2004021993A3 Modified asialo-interferons and uses thereof |
| 06/24/2004 | WO2004019043A3 Polypeptide biomarkers for diagnosing alzheimer's disease |
| 06/24/2004 | WO2004016641A3 Proteins involved in the regulation of energy homeostasis |
| 06/24/2004 | WO2004011650A3 Antigens encoded by alternative reading frame from pathogenic viruses |
| 06/24/2004 | WO2004011498A3 Long lasting natriuretic peptide derivatives |
| 06/24/2004 | WO2004007753A3 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 06/24/2004 | WO2004000231A3 Methods and compositions for the treament of cancer |
| 06/24/2004 | WO2003100025A3 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation |
| 06/24/2004 | WO2003097795A3 Constitutively translocating cell line |
| 06/24/2004 | WO2003095604A3 Purified peptide deformylase from streptococcus pneumoniae |
| 06/24/2004 | WO2003093461A8 Genomic library of cyanophage s-2l and functional analysis |
| 06/24/2004 | WO2003091448A3 696803, a human transporter family member and uses therefor |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003083083A3 Methods of using flt3-ligand in immunization protocols |
| 06/24/2004 | WO2003076631A3 Genetic products differentially expressed in tumors and use thereof |
| 06/24/2004 | WO2003072716A3 Sequence analysis of the tetravalent rotavirus vaccine |
| 06/24/2004 | WO2003068800A3 Isolated peptides which bind to hla molecules and uses thereof |
| 06/24/2004 | WO2003061559A9 Binding peptides specific for the extracellular domain of erbb2 and uses therefor |
| 06/24/2004 | WO2003050238A9 Receptor-targeted adenoviral vectors |
| 06/24/2004 | WO2003049686A3 Stabilization of hypoxia inducible factor (hif) alpha |
| 06/24/2004 | WO2003048185A3 Angiopioetin related factors |
| 06/24/2004 | WO2003033666A3 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | WO2003016473A3 Bovine leptin protein, antisense and antibody |
| 06/24/2004 | WO2003008560A8 A novel g protein-coupled receptor, gave8 |
| 06/24/2004 | WO2002097115A8 Xrcc1 and uses thereof |
| 06/24/2004 | WO2002092758A9 Gastrokines and derived peptides including inhibitors |
| 06/24/2004 | WO2002086075A3 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 06/24/2004 | WO2001066563A8 T1r taste receptors and genes encoding same |
| 06/24/2004 | WO1999053016A3 Expression of alfin1 and methods for producing transgenic plants having increased root growth and root specific gene activation |
| 06/24/2004 | US20040123345 Expression vector coding polypeptide associated with binding and sequestering ionic forms of certain metals in plant tissues for controlling metal deposition in plant tissues; bioremediation |
| 06/24/2004 | US20040123344 Novel gene encoding an f-box protein which regulates leaf longevity in arabidopsis thaliana and mutant gene thereof |
| 06/24/2004 | US20040123343 Expression vector coding polypeptide for use in generating disease, herbicide, heat and drought resistant plants |
| 06/24/2004 | US20040123340 Using expressed sequence tags as tool in the identification of transgenic plants and expression heterologous nuclelotide sequences |
| 06/24/2004 | US20040123338 Nucleic acid molecules and other molecules associated with plants |
| 06/24/2004 | US20040122236 Novel lysophosphatidic acid receptor agonists and antagonists |
| 06/24/2004 | US20040122221 Comprises nuclelotide sequences which cell proliferative agents for use in identifying modulators for prevention and treatment of cancer and organ rejection |
| 06/24/2004 | US20040122220 Comprises nucleotide sequences coding adipocyte regulatory polypeptide for use in prevention and/or treatment of obesity, diabetes, hypertrophy of cardiac and skeletal muscle, autoimmune and cell proliferative disorders |
| 06/24/2004 | US20040122217 Lectin compositions and methods for modulating an immune response to an antigen |
| 06/24/2004 | US20040122216 A mutein recombinant tissue protective cytokine lacking at least one activity selected from group consisting of increasing hematocrit, vasoactive action, hyperactivating platelets, pro-coagulant activities and increasing production of thrombocytes |
| 06/24/2004 | US20040122215 Human Ependymin |